Schedule of Warrant Activity (Details) - Warrant [Member] - $ / shares |
12 Months Ended | |
|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Class of Warrant or Right [Line Items] | ||
| Number of Warrants, Balance | 49,446 | |
| Weighted Average Exercise Price, Balance | $ 5.77 | |
| Weighted average remaining contractual term | 8 months 12 days | |
| Number of Warrants, Granted | ||
| Weighted Average Exercise Price, Granted | ||
| Number of Warrants, Exercised | ||
| Weighted Average Exercise Price, Exercised | ||
| Number of Warrants, Cancelled | ||
| Weighted Average Exercise Price, Cancelled | ||
| Number of Warrants, Expired | (49,446) | |
| Weighted Average Exercise Price, Expired | $ 5.77 | |
| Number of Warrants, Balance | 49,446 | |
| Weighted Average Exercise Price, Balance | $ 5.77 | |
| Number of Warrants, Exercisable | ||
| Weighted Average Exercise Price, Balance | ||
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award equity instruments other than options exercisable weighted average grant date fair value. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments number of warrants exercisable. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average remaining contractual term. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangements by share based payment award other than options exercises in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangements by share based payment award other than options expirations in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|